Image credit: AP Photo/Kathy Young

In a First, a Cannabis-Derived Pharma Product Is Descheduled in the US

The DEA has taken Epidiolex, a CBD-based formula for rare forms of epilepsy, completely off its list of controlled substances. Why? The 2018 Farm Bill.

CBD
Newsletter

Cronos exits US • Australia’s adult use push • UC Berkeley launches oral history series • & more …

An excerpt from recent editions of the Cannabis Wire Daily newsletter.

New York

New York’s Cannabis Equity Fund Recalibrates: “The Markets Have Changed” 

Cannabis regulators met on Tuesday for the second time in May to also approve emergency enforcement rules and a settlement related to a lawsuit that blocked licensing in parts of the state.